Top 5 Takeaways Significant Contribution by FRPP: The Federal Retail Pharmacy Program (FRPP) partners administered 67.7% of the 59.8 million COVID-19 bivalent vaccine doses in the U.S. during the study
Tag: Vaccine
Top 5 Takeaways FDA Approvals and ACIP Recommendations: The FDA issued Emergency Use Authorizations for the Moderna and Pfizer-BioNTech COVID-19 vaccines for children aged 6 months–5 years and 6 months–4
Top 5 Takeaways Reduced Reactions Post-Booster: Immunocompromised individuals aged ≥12 years reported fewer local and systemic reactions after the fourth dose (mRNA booster) compared to after the third dose of
Top 5 Takeaways Emergency Use Authorization Granted: The FDA issued an EUA for the Novavax COVID-19 vaccine on July 13, 2022, for primary immunization in adults aged ≥18 years. ACIP’s
Top 5 Takeaways Significant progress in measles vaccination coverage: From 2003 to 2020, estimated coverage for the first and second doses of measles-containing vaccine (MCV1 and MCV2) in the South-East
Top 5 Takeaways Similar Adverse Reaction Frequencies: Children aged 5–11 years reported local and systemic reactions to the Pfizer-BioNTech COVID-19 vaccine booster dose with similar frequency as after the second
Top 5 Takeaways Booster Dose Uptake: Approximately half of the eligible population aged ≥5 years (106.3 million out of 214.4 million) received a COVID-19 vaccine booster dose. Second Booster Dose:
Top 5 Takeaways Widespread Vaccine Safety in Young Children: Among children aged 6 months–5 years, COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) have shown a safety profile with primarily mild to
Top 5 Takeaways Decline in Vaccination Intent and Confidence Over 3 Months: Parental intent to vaccinate children under 5 against COVID-19 and confidence in vaccine safety and effectiveness decreased within
Top 5 Takeaways ACIP Recommendations: The Advisory Committee on Immunization Practices (ACIP) now recommends the use of the 15-valent pneumococcal conjugate vaccine (PCV15) for persons under 19 years, aligning with